These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 23260686)
1. Update on Emerging Infections: news from the Centers for Disease Control and Prevention. Update to the CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections . Maldonado NG; Takhar SS Ann Emerg Med; 2013 Jan; 61(1):91-5. PubMed ID: 23260686 [No Abstract] [Full Text] [Related]
2. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837 [TBL] [Abstract][Full Text] [Related]
3. Retreatment rates for uncomplicated gonorrhea infection: comparing ceftriaxone and azithromycin versus ceftriaxone and doxycycline. Schumacher CM; Ghanem KG Sex Transm Dis; 2013 Jul; 40(7):539-45. PubMed ID: 23965767 [TBL] [Abstract][Full Text] [Related]
4. Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013. Singh AE; Gratrix J; Martin I; Friedman DS; Hoang L; Lester R; Metz G; Ogilvie G; Read R; Wong T Sex Transm Dis; 2015 Jun; 42(6):331-6. PubMed ID: 25970311 [TBL] [Abstract][Full Text] [Related]
5. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503 [TBL] [Abstract][Full Text] [Related]
6. Adherence to Centers for Disease Control and Prevention Gonococcal Treatment Guidelines Among Chicago Health Care Providers, 2011-2012. Tabidze IL; Nicholson TF; Mikati T; Benbow N; Mehta SD Sex Transm Dis; 2015 Aug; 42(8):422-8. PubMed ID: 26165433 [TBL] [Abstract][Full Text] [Related]
7. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634 [TBL] [Abstract][Full Text] [Related]
8. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Ison CA; Hussey J; Sankar KN; Evans J; Alexander S Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528 [TBL] [Abstract][Full Text] [Related]
9. Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae? Rice LB Sex Transm Infect; 2015 Jun; 91(4):238-40. PubMed ID: 25926405 [No Abstract] [Full Text] [Related]
10. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558 [TBL] [Abstract][Full Text] [Related]
12. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection. Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431 [TBL] [Abstract][Full Text] [Related]
13. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(14):332-6. PubMed ID: 17431378 [TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant Terkelsen D; Tolstrup J; Johnsen CH; Lund O; Larsen HK; Worning P; Unemo M; Westh H Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067905 [TBL] [Abstract][Full Text] [Related]
15. Variation in adherence to the treatment guidelines for Neisseria gonorrhoeae by clinical practice setting, California, 2009 to 2011. Lechtenberg RJ; Samuel MC; Bernstein KT; Lahiff M; Olson N; Bauer HM Sex Transm Dis; 2014 May; 41(5):338-44. PubMed ID: 24722391 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance. Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V; BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220 [TBL] [Abstract][Full Text] [Related]
17. Partner Therapy in Sexually Transmitted Infections: A Teachable Moment. Keshvani N; Nijhawan A; Gupta A JAMA Intern Med; 2018 Aug; 178(8):1108-1109. PubMed ID: 29889926 [No Abstract] [Full Text] [Related]
18. Treatment of gonococcal infection: when one drug is not enough. Kransdorf LN; Kling JM; Mayer AP J Womens Health (Larchmt); 2014 Jul; 23(7):627-8. PubMed ID: 24918549 [No Abstract] [Full Text] [Related]
19. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013. Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P; Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy for gonorrhoea: in vitro synergy testing. Pereira R; Cole MJ; Ison CA J Antimicrob Chemother; 2013 Mar; 68(3):640-3. PubMed ID: 23152483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]